搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pasteurella multocida L-threonine dehydratase biosynthetic IlvA (ilvA), partial CSB-YP883827ESG
CSB-EP883827ESG
CSB-BP883827ESG
CSB-MP883827ESG
CSB-EP883827ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida LPS-assembly protein lptD (lptD), partial CSB-YP883828ESG
CSB-EP883828ESG
CSB-BP883828ESG
CSB-MP883828ESG
CSB-EP883828ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida FKBP-type peptidyl-prolyl cis-trans isomerase slyD (slyD) CSB-YP883829ESG
CSB-EP883829ESG
CSB-BP883829ESG
CSB-MP883829ESG
CSB-EP883829ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP883830ESG
CSB-EP883830ESG
CSB-BP883830ESG
CSB-MP883830ESG
CSB-EP883830ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida ATP synthase subunit delta (atpH) CSB-YP883831ESG
CSB-EP883831ESG
CSB-BP883831ESG
CSB-MP883831ESG
CSB-EP883831ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida UPF0324 membrane protein PM1461 (PM1461), partial CSB-YP883832ESG
CSB-EP883832ESG
CSB-BP883832ESG
CSB-MP883832ESG
CSB-EP883832ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Glycerol-3-phosphate dehydrogenase [NAD (P)+] (gpsA) CSB-YP883833ESG
CSB-EP883833ESG
CSB-BP883833ESG
CSB-MP883833ESG
CSB-EP883833ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida 50S ribosomal protein L23 (rplW) CSB-YP883834ESG
CSB-EP883834ESG
CSB-BP883834ESG
CSB-MP883834ESG
CSB-EP883834ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida 30S ribosomal protein S14 (rpsN) CSB-YP883835ESG
CSB-EP883835ESG
CSB-BP883835ESG
CSB-MP883835ESG
CSB-EP883835ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Ribose import ATP-binding protein RbsA 2 (rbsA2), partial CSB-YP883836ESG
CSB-EP883836ESG
CSB-BP883836ESG
CSB-MP883836ESG
CSB-EP883836ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP883837ESG
CSB-EP883837ESG
CSB-BP883837ESG
CSB-MP883837ESG
CSB-EP883837ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Probable Fe (2+)-trafficking protein (PM1320) CSB-YP883838ESG
CSB-EP883838ESG
CSB-BP883838ESG
CSB-MP883838ESG
CSB-EP883838ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida 50S ribosomal protein L19 (rplS) CSB-YP883839ESG
CSB-EP883839ESG
CSB-BP883839ESG
CSB-MP883839ESG
CSB-EP883839ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized aldolase PM1278 (PM1278) CSB-YP883840ESG
CSB-EP883840ESG
CSB-BP883840ESG
CSB-MP883840ESG
CSB-EP883840ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida 30S ribosomal protein S21 (rpsU) CSB-YP883841ESG
CSB-EP883841ESG
CSB-BP883841ESG
CSB-MP883841ESG
CSB-EP883841ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized protein PM1205 (PM1205) CSB-YP883842ESG
CSB-EP883842ESG
CSB-BP883842ESG
CSB-MP883842ESG
CSB-EP883842ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized lipoprotein PM1176 (PM1176) CSB-YP883843ESG
CSB-EP883843ESG
CSB-BP883843ESG
CSB-MP883843ESG
CSB-EP883843ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Chromosomal replication initiator protein DnaA (dnaA) CSB-YP883844ESG
CSB-EP883844ESG
CSB-BP883844ESG
CSB-MP883844ESG
CSB-EP883844ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Uncharacterized protein PM1122 (PM1122) CSB-YP883845ESG
CSB-EP883845ESG
CSB-BP883845ESG
CSB-MP883845ESG
CSB-EP883845ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pasteurella multocida Ribosomal protein L11 methyltransferase (prmA) CSB-YP883846ESG
CSB-EP883846ESG
CSB-BP883846ESG
CSB-MP883846ESG
CSB-EP883846ESG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>